These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. The use of M and B 938 in myelomatosis. WARD HW J Fac Radiol; 1958 Oct; 9(4):221-2. PubMed ID: 24544992 [No Abstract] [Full Text] [Related]
45. [Treatment of malignant systemic diseases]. VIDEBAEK A Nord Med; 1956 Mar; 55(10):320-3. PubMed ID: 13309805 [No Abstract] [Full Text] [Related]
46. [Experiences with high dosage prednisone therapy and its side-effects in hemoblastosis, especially in plasmocytoma]. WITTEKIND D; SESSNER HH Dtsch Arch Klin Med; 1960; 206():636-62. PubMed ID: 13786084 [No Abstract] [Full Text] [Related]
47. Mitomycin C (NSC-26980)--an evaluation of the Japanese reports. FRANK W; OSTERBERG AE Cancer Chemother Rep; 1960 Nov; 9():114-9. PubMed ID: 13701377 [No Abstract] [Full Text] [Related]
48. Jaundice during treatment of myelomatosis with M & B 938. DENMAN AM; WARD HW Br Med J; 1960 Feb; 1(5171):482. PubMed ID: 13815928 [No Abstract] [Full Text] [Related]
49. Chemotherapeutic control of multiple myeloma. SAMPEY JR J S C Med Assoc; 1959 May; 55(5):183-4. PubMed ID: 13655275 [No Abstract] [Full Text] [Related]
50. Urethane-induced hepatic failure in man. WEISS DL; DE LOS SANTOS R Am J Med; 1960 Mar; 28():476-81. PubMed ID: 13843702 [No Abstract] [Full Text] [Related]
51. On the effect of corticotropin (ACTH) on myelomatosis with special reference to the bone marrow and the serum proteins. Effersøe P; Gormsen H; Harboe N; Nielsen SE; Videbaek AA Acta Med Scand; 1952 May; 143(1):63-82. PubMed ID: 12976012 [No Abstract] [Full Text] [Related]
52. The use of combination 5-fluorouracil and supervoltage irradiation therapy in advanced carcinoma of the urinary bladder--a preliminary report. WOODRUFF MW; MURPHY WT; HODSON JM Cancer Chemother Rep; 1962 Aug; 21():123-7. PubMed ID: 14008235 [No Abstract] [Full Text] [Related]
53. [Use of some antitumor antibiotics for the treatment of leukoses]. KAVERZNEVA MM Probl Gematol Pereliv Krovi; 1962 Jul; 7():31-9. PubMed ID: 14454519 [No Abstract] [Full Text] [Related]
54. [Extramedullary plasmocytoma of the vulva]. BERGER J Hautarzt; 1956 Apr; 7(4):168-71. PubMed ID: 13318614 [No Abstract] [Full Text] [Related]
55. [Preliminary report on the treatment of plasmocytoma with an ethyleneimino-quinone preparation (E 39 Bayer)]. HEILMANN D Dtsch Med J; 1957 Nov; 8(11):565-9. PubMed ID: 13490130 [No Abstract] [Full Text] [Related]
56. Anti-virus and anti-tumor agents. ARBATSKY YG ICRS Med Rep; 1961; 3():25-9. PubMed ID: 13862043 [No Abstract] [Full Text] [Related]
57. Clinical experience with a new antitumor agent chromomycin. KURU M Cancer Chemother Rep; 1961 Jul; 13():91-7. PubMed ID: 13755340 [No Abstract] [Full Text] [Related]
58. An experiment in the use of sarcolysin in myelomatosis. ALEKSEYEV GA; PETROV KI Probl Gematol Pereliv Krovi; 1961; 6():801-9. PubMed ID: 14036660 [No Abstract] [Full Text] [Related]
59. The effect of 1-aminocyclopentane carboxylic acid (NSC-1026) on mouse plasmacytoma. HAYES DM; SPURR CL Cancer Chemother Rep; 1961 Oct; 14():91-2. PubMed ID: 13905642 [No Abstract] [Full Text] [Related]
60. Clinical experience with streptonigrin. HUMPHREY EW; BLANK N Cancer Chemother Rep; 1961 Jun; 12():99-103. PubMed ID: 13716809 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]